Cedars-Sinai announced its regenerative medicine investigators have received approval from the U.S. Food and Drug Administration to test a combination stem cell-gene therapy they developed to stall the progression of Lou Gehrig’s disease. The approval allows patients to receive a new investigational drug in a few months when the study begins at the Cedar-Sinai Board […]